Of risks and ratios: the usefulness of angiogenic balance for diagnosing preeclampsia at different gestational ages.
作者信息
Gilbert Jeffrey S, Babcock Sara A, Regal Ronald R, Regal Jean F
机构信息
Department of Human Physiology, University of Oregon, Eugene, OR 97403-1240.
出版信息
Hypertension. 2014 Feb;63(2):210-1. doi: 10.1161/HYPERTENSIONAHA.113.02050. Epub 2013 Oct 28.
Abstract
摘要
相似文献
1
Of risks and ratios: the usefulness of angiogenic balance for diagnosing preeclampsia at different gestational ages.风险与比率：血管生成平衡在不同孕周诊断子痫前期中的作用
Hypertension. 2014 Feb;63(2):210-1. doi: 10.1161/HYPERTENSIONAHA.113.02050. Epub 2013 Oct 28.
2
New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.新的妊娠期特异性截断值用于可溶性 fms 样酪氨酸激酶-1/胎盘生长因子比值作为子痫前期的诊断试验。
Hypertension. 2014 Feb;63(2):346-52. doi: 10.1161/HYPERTENSIONAHA.113.01787. Epub 2013 Oct 28.
3
[Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience].[在临床常规中使用血管生成因子（sFlt-1/PlGF 比值）来确诊子痫前期：初步经验]
Z Geburtshilfe Neonatol. 2010 Dec;214(6):234-8. doi: 10.1055/s-0030-1262827. Epub 2011 Jan 4.
4
Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.多中心前瞻性临床研究以评估疑似子痫前期孕妇的短期结局预测（PROGNOSIS）：研究方案
BMC Pregnancy Childbirth. 2014 Sep 18;14:324. doi: 10.1186/1471-2393-14-324.
5
Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice.可溶性血管内皮生长因子受体-1/胎盘生长因子比值在单胎妊娠子痫前期预测和诊断中的应用：对临床实践的意义
Ultrasound Obstet Gynecol. 2015 Mar;45(3):241-6. doi: 10.1002/uog.14799.
6
Circulating angiogenic factors and preeclampsia.循环血管生成因子与子痫前期
N Engl J Med. 2004 May 6;350(19):2003-4; author reply 2003-4. doi: 10.1056/NEJM200405063501918.
7
[Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].[胎盘血管生成因子作为子痫前期生物标志物对临床医生的潜在价值]
Nephrol Ther. 2019 Nov;15(6):413-429. doi: 10.1016/j.nephro.2018.10.005. Epub 2019 Mar 30.
8
[Can pre-eclampsia be predicted?].[子痫前期能够被预测吗？]
Tidsskr Nor Laegeforen. 2011 May 6;131(8):806-7. doi: 10.4045/tidsskr.10.1448.
9
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.一项关于孕早期和孕中期母体血浆血管生成因子和抗血管生成因子浓度在识别先兆子痫患者中的价值的前瞻性队列研究。
J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.
10
Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.使用多种标志物的筛查模型用于低风险妊娠中晚发型子痫前期的早期检测。
BMC Pregnancy Childbirth. 2014 Jan 20;14:35. doi: 10.1186/1471-2393-14-35.
本文引用的文献
1
New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia.新的妊娠期特异性截断值用于可溶性 fms 样酪氨酸激酶-1/胎盘生长因子比值作为子痫前期的诊断试验。
Hypertension. 2014 Feb;63(2):346-52. doi: 10.1161/HYPERTENSIONAHA.113.01787. Epub 2013 Oct 28.
2
Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy.严重子痫前期患者尿中 C5b-9 的排泄：妊娠期间补体激活平衡的倾斜。
Hypertension. 2013 Dec;62(6):1040-5. doi: 10.1161/HYPERTENSIONAHA.113.01420. Epub 2013 Sep 23.
3
Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation.预测 19-31 孕周采血后 4 周内子痫前期即将发生的可溶性 fms 样酪氨酸激酶 1/胎盘生长因子比值的血浆水平起始阈值。
Hypertens Res. 2013 Dec;36(12):1073-80. doi: 10.1038/hr.2013.95. Epub 2013 Aug 22.
4
Recent advances in the understanding of the pathophysiology of preeclampsia.子痫前期病理生理学认识的最新进展。
Hypertension. 2013 Oct;62(4):666-73. doi: 10.1161/HYPERTENSIONAHA.113.00588. Epub 2013 Jul 29.
5
Integrated proteomics pipeline yields novel biomarkers for predicting preeclampsia.综合蛋白质组学分析流程为预测子痫前期提供了新的生物标志物。
Hypertension. 2013 Jun;61(6):1281-8. doi: 10.1161/HYPERTENSIONAHA.113.01168. Epub 2013 Apr 1.
6
Threshold of soluble fms-like tyrosine kinase 1/placental growth factor ratio for the imminent onset of preeclampsia.可溶性 fms 样酪氨酸激酶 1/胎盘生长因子比值预测子痫前期发生的界值。
Hypertension. 2011 Nov;58(5):859-66. doi: 10.1161/HYPERTENSIONAHA.111.174417. Epub 2011 Sep 26.
7
The genetic sonogram: comparing the use of likelihood ratios versus logistic regression coefficients for Down syndrome screening.遗传超声检查：比较使用似然比与 logistic 回归系数进行唐氏综合征筛查。
J Ultrasound Med. 2011 Apr;30(4):463-9. doi: 10.7863/jum.2011.30.4.463.
8
Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.重组血管内皮生长因子 121 输注降低胎盘缺血诱导高血压大鼠的血压并改善肾功能。
Hypertension. 2010 Feb;55(2):380-5. doi: 10.1161/HYPERTENSIONAHA.109.141937. Epub 2009 Dec 21.
9
Maternal preeclampsia predicts the development of bronchopulmonary dysplasia.母亲子痫前期可预测支气管肺发育不良的发生。
J Pediatr. 2010 Apr;156(4):532-6. doi: 10.1016/j.jpeds.2009.10.018. Epub 2009 Dec 14.
10
Preeclampsia and angiogenic imbalance.子痫前期与血管生成失衡
Annu Rev Med. 2008;59:61-78. doi: 10.1146/annurev.med.59.110106.214058.
Zotero 插件